|
⚲
|
| IBS Capital LLC
✚
|
|
|---|---|
| CRD # | 160585 |
| SEC # | 801-74238 |
| CIK # | 0001414860 |
| AUM | $109.0 MM (2023-03-20) |
| Employees | 4 (50% Investors, 0% Brokers) |
| Phone | 617-261-5327 |
| Address | 3 Post Office Square Boston, MA 02109 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($MM) |
|---|
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | The IBS Opportunity Fund Ltd | [2012-02-15] | 25.7 | 9.9 |
| HF | The IBS Turnaround Fund LP | 2012-02-15 | 32.4 | |
| HF | The IBS Turnaround Fund QP A Limited Partnership | [2012-02-15] | 247.1 | 66.8 |
| AUM Breakdown | Accounts | AUM ($MM) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 109.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 109.0 |
| By Discretionary | ||
| Discretionary | 3 | 109.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 109.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 9.9 | |
| United States Persons | 99.1 | |
| Total | 3 | 109.0 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Shonalee Munroe | 3 | ||
| David Blair | 19 | ||
| David Taft | 14 | ||
| James Horne | 3 | ||
| Theresa Taft | 2 | ||
| Izabella Koeijers | 1 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 4 | [0001414860] | |
| SC 13G | [0001414860] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| IBS Capital LLC | AGEX Therapeutics Inc | [2019-02-14] |
| Form 3/4/5 Subject | 2011 - 2024 |
|---|---|
| Taft David A | |
| IBS Capital LLC | |
| Applied Minerals, Inc. | |
| IBS Turnaround Fund QP A Ltd Partnership |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Marlowe Partners LP
✚
|
NY | 0.1 |
|
Gritstone Asset Management LLC
✚
|
MD | 0.1 |
|
Worm Capital LLC
✚
|
TX | 0.1 |
|
Maytus Capital Management LLC
✚
|
NY | 0.1 |
|
Saltoro Capital LP
✚
|
TX | 0.1 |
|
Park Shore Partners LLC
✚
|
PA | 0.1 |
|
Bayard Asset Management LLC
✚
|
NJ | 0.1 |
|
Silva Capital Management LLC
✚
|
IL | 0.1 |
|
A6 Capital Management LP
✚
|
NY | 0.1 |
|
Galileo Investment Management LLC
✚
|
NY | 0.1 |